• Bartlema YM, Oosterhuis JA, Journee-de Korver JG, Tjho-Heslinga RE & Keunen JE (2003): Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years’ experience. Br J Ophthalmol 87: 13701373.
  • Basu S, Binder RJ, Suto R, Anderson KM & Srivastava PK (2000): Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12: 15391546.
  • Bronkhorst IH, Ly LV, Jordanova ES, Vrolijk H, Versluis M, Luyten GP & Jager MJ (2011): Detection of M2 macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci 52: [Epub ahead of print].
  • Burnier MN Jr, McLean IW & Gamel JW (1991): Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 68: 809814.
  • Donato R (2003): Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540551.
  • Journee-de Korver JG & Keunen JE (2002): Thermotherapy in the management of choroidal melanoma. Prog Retin Eye Res 21: 303317.
  • Kincaid MC (1998): Uveal Melanoma. Cancer Control 5: 299309.
  • Liu Q, Zhai B, Yang W et al. (2009): Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther 17: 20492057.
  • Maat W, Ly LV, Jordanova ES, de Wolff-Rouendaal D, Schalij-Delfos NE & Jager MJ (2008): Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci 49: 505510.
  • Makitie T, Summanen P, Tarkkanen A & Kivela T (2001): Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 42: 14141421.
  • Mantovani A, Sozzani S, Locati M, Allavena P & Sica A (2002): Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549555.
  • Missotten GS, Journee-de Korver JG, de Wolff-Rouendaal D, Keunen JE, Schlingemann RO & Jager MJ (2003): Heat shock protein expression in the eye and in uveal melanoma. Invest Ophthalmol Vis Sci 44: 30593065.
  • Oosterhuis JA, Journee-de Korver HG & Keunen JE (1998): Transpupillary thermotherapy: results in 50 patients with choroidal melanoma. Arch Ophthalmol 116: 157162.
  • Rem AI (2004): Transscleral thermotherapy for choroidal melanoma, PhD thesis, Leiden. University Medical Center, Leiden, The Netherlands.
  • Rem AI, Oosterhuis JA, Korver JG & van den Berg TJ (2001): Transscleral laser thermotherapy of hamster Greene melanoma: inducing tumour necrosis without scleral damage. Melanoma Res 11: 503509.
  • Schurmans LR, Blom DJ, De Waard-Siebinga I, Keunen JE, Prause JU & Jager MJ (1999): Effects of transpupillary thermotherapy on immunological parameters and apoptosis in a case of primary uveal melanoma. Melanoma Res 9: 297302.
  • Shields CL, Cater J, Shields JA, Chao A, Krema H, Materin M & Brady LW (2002): Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 120: 933940.
  • Sica A, Schioppa T, Mantovani A & Allavena P (2006): Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717727.
  • Srivastava PK, DeLeo AB & Old LJ (1986): Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 83: 34073411.
  • Wells AD, Rai SK, Salvato MS, Band H & Malkovsky M (1998): Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol 10: 609617.